Overview Iovance
OverviewIovance is an immune-oncology company focused on the development and commercialization of novel cancer immunotherapies based on TIL. The companys lead candidate is an autologous ready-to-infuse cell therapy that has demonstrated distinctive efficacy in the treatment of metasta
OverviewIovance is an immune-oncology company focused on the development and commercialization of novel cancer immunotherapies based on TIL. The companys lead candidate is an autologous ready-to-infuse cell therapy that has demonstrated distinctive efficacy in the treatment of metasta